semaglutide canada cost Cheaper obesity medications could come to this summer, as Health Canada reviews generics Ozempic and Wegovy could soon

Risks/ disadvantages of GLP-1 agonists: Nausea and vomiting (far less likely when starting on a very low dose and titrating up slowly) Diarrhoea Dizziness and tiredness Mild tachycardia (increased heart rate) Headaches Temporary itchiness /redness around injection sites Dry mouth/reduced salivary secretions Low blood sugar Rare but more serious side effects: Pancreatitis More serious gut side effects because of stagnated gut movement Medullary thyroid cancer Sudden kidney injury (usually because of reduced volume intake or vomiting) Worsening of diabetic retinopathy (diabetes related eye disease) Allergic reactions Gallbladder or biliary disease Depression and suicidal ideation Aspiration (food or liquid getting into lungs) during anaesthesia as the stomach empties more slowly- ideally the medication should be stopped for 2-4 weeks prior to elective surgery

The ubiquitin-specific protease USP8 directly deubiquitinates SQSTM1/p62 to suppress its autophagic activity

Common side effects include nausea, diarrhea and constipation

Patients should discuss with their primary care physician and/or endocrinologist whether they should cease GLP-1 medication use in order to balance the risk of vision loss from NAION in the fellow eye with the hypoglycemic and cardiovascular benefits from treatment